Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hydrogen Sulfide | 15 | 2023 | 39 | 4.820 |
Why?
|
Iris | 20 | 2010 | 26 | 3.000 |
Why?
|
Retina | 18 | 2018 | 280 | 2.880 |
Why?
|
Ciliary Body | 14 | 2018 | 23 | 2.060 |
Why?
|
Cattle | 36 | 2021 | 477 | 1.820 |
Why?
|
Norepinephrine | 19 | 2015 | 110 | 1.690 |
Why?
|
D-Aspartic Acid | 7 | 2018 | 9 | 1.450 |
Why?
|
Hydrogen Peroxide | 12 | 2021 | 190 | 1.430 |
Why?
|
Sympathetic Nervous System | 10 | 2015 | 74 | 1.310 |
Why?
|
Eye | 7 | 2011 | 71 | 1.280 |
Why?
|
Cyclic AMP | 9 | 2012 | 131 | 1.270 |
Why?
|
Ciliary Arteries | 3 | 2018 | 6 | 1.140 |
Why?
|
Intraocular Pressure | 6 | 2018 | 112 | 1.100 |
Why?
|
Ophthalmic Solutions | 4 | 2018 | 18 | 1.080 |
Why?
|
Isoprostanes | 6 | 2014 | 14 | 1.060 |
Why?
|
Animals | 72 | 2023 | 15081 | 1.050 |
Why?
|
Cysteine | 8 | 2019 | 98 | 1.040 |
Why?
|
Aspartic Acid | 6 | 2018 | 47 | 1.030 |
Why?
|
Synaptic Transmission | 9 | 2015 | 146 | 0.960 |
Why?
|
Muscle Contraction | 5 | 2018 | 66 | 0.930 |
Why?
|
Neurotransmitter Agents | 4 | 2011 | 63 | 0.830 |
Why?
|
Serotonin Antagonists | 5 | 2018 | 23 | 0.830 |
Why?
|
Citrates | 8 | 2009 | 14 | 0.820 |
Why?
|
Aqueous Humor | 2 | 2017 | 18 | 0.760 |
Why?
|
Prostaglandins | 8 | 2015 | 27 | 0.720 |
Why?
|
Dose-Response Relationship, Drug | 17 | 2018 | 1039 | 0.710 |
Why?
|
Organothiophosphorus Compounds | 4 | 2018 | 7 | 0.680 |
Why?
|
Tritium | 10 | 2011 | 51 | 0.670 |
Why?
|
Morpholines | 4 | 2018 | 69 | 0.660 |
Why?
|
Peroxides | 4 | 2005 | 20 | 0.630 |
Why?
|
Receptor, Serotonin, 5-HT2C | 1 | 2018 | 5 | 0.630 |
Why?
|
Receptor, Serotonin, 5-HT2B | 1 | 2018 | 6 | 0.630 |
Why?
|
Glaucoma | 2 | 2017 | 85 | 0.600 |
Why?
|
Cyclooxygenase Inhibitors | 9 | 2012 | 30 | 0.600 |
Why?
|
Cystathionine gamma-Lyase | 6 | 2015 | 12 | 0.590 |
Why?
|
Phenylephrine | 2 | 2015 | 36 | 0.590 |
Why?
|
Sulfides | 7 | 2023 | 62 | 0.580 |
Why?
|
Eye Diseases | 3 | 2018 | 24 | 0.570 |
Why?
|
Dinoprost | 5 | 2008 | 22 | 0.560 |
Why?
|
Piperidines | 3 | 2015 | 77 | 0.560 |
Why?
|
Dinoprostone | 7 | 2009 | 63 | 0.560 |
Why?
|
Muscle, Smooth | 4 | 2010 | 58 | 0.550 |
Why?
|
Muscle Relaxation | 4 | 2015 | 19 | 0.530 |
Why?
|
Cystathionine beta-Synthase | 5 | 2015 | 12 | 0.510 |
Why?
|
Pyrrolidines | 1 | 2015 | 29 | 0.510 |
Why?
|
Organophosphorus Compounds | 1 | 2015 | 37 | 0.500 |
Why?
|
Glycine | 4 | 2012 | 47 | 0.500 |
Why?
|
Electric Stimulation | 15 | 2015 | 184 | 0.480 |
Why?
|
Vasoconstrictor Agents | 4 | 2015 | 41 | 0.470 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2015 | 130 | 0.470 |
Why?
|
Potassium Chloride | 5 | 2009 | 28 | 0.470 |
Why?
|
Vasodilation | 1 | 2013 | 65 | 0.450 |
Why?
|
Swine | 6 | 2023 | 184 | 0.420 |
Why?
|
Flurbiprofen | 8 | 2009 | 10 | 0.420 |
Why?
|
KATP Channels | 4 | 2015 | 11 | 0.410 |
Why?
|
Retinal Pigment Epithelium | 1 | 2012 | 30 | 0.400 |
Why?
|
Oxidative Stress | 8 | 2021 | 938 | 0.400 |
Why?
|
Calcium | 3 | 2018 | 480 | 0.380 |
Why?
|
Cataract | 2 | 2021 | 26 | 0.370 |
Why?
|
Catecholamines | 2 | 2018 | 44 | 0.360 |
Why?
|
F2-Isoprostanes | 3 | 2011 | 20 | 0.350 |
Why?
|
Rabbits | 12 | 2016 | 283 | 0.340 |
Why?
|
Serotonin | 4 | 2002 | 123 | 0.330 |
Why?
|
Muscarinic Antagonists | 1 | 2008 | 12 | 0.330 |
Why?
|
Uterus | 4 | 1991 | 55 | 0.330 |
Why?
|
Air Pollutants | 1 | 2009 | 94 | 0.320 |
Why?
|
Glutamic Acid | 3 | 2009 | 128 | 0.300 |
Why?
|
Histamine | 2 | 2006 | 18 | 0.300 |
Why?
|
Catalase | 2 | 2000 | 109 | 0.300 |
Why?
|
Calcium Channel Blockers | 3 | 2003 | 56 | 0.300 |
Why?
|
Free Radicals | 2 | 2005 | 74 | 0.290 |
Why?
|
Carbachol | 5 | 2010 | 19 | 0.290 |
Why?
|
Aporphines | 2 | 2005 | 16 | 0.290 |
Why?
|
Uvea | 2 | 2015 | 3 | 0.290 |
Why?
|
Plant Extracts | 5 | 2004 | 286 | 0.280 |
Why?
|
Appetite Depressants | 2 | 2004 | 9 | 0.280 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 2 | 2000 | 41 | 0.270 |
Why?
|
Ischemia | 1 | 2006 | 46 | 0.270 |
Why?
|
Cannabinoids | 1 | 2006 | 56 | 0.270 |
Why?
|
Rats | 15 | 2012 | 3483 | 0.260 |
Why?
|
Arachidonic Acid | 1 | 2005 | 35 | 0.250 |
Why?
|
Excitatory Amino Acid Agonists | 2 | 2001 | 48 | 0.250 |
Why?
|
Receptors, Prostaglandin | 4 | 2009 | 10 | 0.250 |
Why?
|
Receptors, Serotonin | 4 | 2018 | 22 | 0.240 |
Why?
|
Receptors, Thromboxane | 4 | 2008 | 4 | 0.240 |
Why?
|
Lutein | 1 | 2024 | 5 | 0.240 |
Why?
|
Arachidonic Acids | 1 | 2004 | 24 | 0.240 |
Why?
|
Vitreous Body | 1 | 2003 | 11 | 0.230 |
Why?
|
Alanine | 1 | 2003 | 30 | 0.230 |
Why?
|
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 2 | 2001 | 11 | 0.230 |
Why?
|
Lipid Peroxidation | 3 | 2004 | 140 | 0.230 |
Why?
|
Adrenergic alpha-Agonists | 2 | 1997 | 34 | 0.230 |
Why?
|
Body Weight | 5 | 2007 | 434 | 0.220 |
Why?
|
Isometric Contraction | 2 | 2015 | 23 | 0.220 |
Why?
|
Amino Acids | 1 | 2003 | 145 | 0.220 |
Why?
|
Cerebral Cortex | 2 | 2002 | 290 | 0.210 |
Why?
|
Neurons | 1 | 2009 | 1175 | 0.210 |
Why?
|
Glucose | 1 | 2003 | 230 | 0.210 |
Why?
|
Receptors, Neurotransmitter | 1 | 2001 | 21 | 0.200 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2001 | 99 | 0.200 |
Why?
|
Receptors, Muscarinic | 3 | 2010 | 18 | 0.200 |
Why?
|
Organ Culture Techniques | 3 | 2008 | 103 | 0.200 |
Why?
|
Garcinia cambogia | 4 | 2004 | 4 | 0.190 |
Why?
|
Uterine Contraction | 3 | 1991 | 6 | 0.190 |
Why?
|
Alkynes | 2 | 2012 | 50 | 0.190 |
Why?
|
Hydrazines | 4 | 2009 | 21 | 0.180 |
Why?
|
Fatty Acids, Unsaturated | 4 | 2009 | 34 | 0.180 |
Why?
|
Drug Synergism | 4 | 2003 | 177 | 0.180 |
Why?
|
Nitric Oxide | 2 | 2015 | 316 | 0.180 |
Why?
|
Prostaglandins F, Synthetic | 2 | 2016 | 6 | 0.170 |
Why?
|
Thioctic Acid | 2 | 2016 | 14 | 0.170 |
Why?
|
Lens, Crystalline | 1 | 2019 | 13 | 0.170 |
Why?
|
Enzyme Inhibitors | 3 | 2015 | 433 | 0.170 |
Why?
|
Intracellular Fluid | 1 | 1998 | 26 | 0.170 |
Why?
|
Humans | 23 | 2024 | 37093 | 0.160 |
Why?
|
Chromaffin Cells | 1 | 2018 | 4 | 0.160 |
Why?
|
Ophthalmic Artery | 1 | 2018 | 3 | 0.160 |
Why?
|
Exocytosis | 1 | 2018 | 47 | 0.160 |
Why?
|
Excitatory Amino Acids | 1 | 2017 | 7 | 0.160 |
Why?
|
Anterior Eye Segment | 1 | 2017 | 8 | 0.150 |
Why?
|
Anti-Obesity Agents | 2 | 2009 | 10 | 0.150 |
Why?
|
Cells, Cultured | 4 | 2018 | 1518 | 0.140 |
Why?
|
Reactive Oxygen Species | 3 | 2002 | 461 | 0.140 |
Why?
|
Xanthones | 2 | 2009 | 2 | 0.140 |
Why?
|
Cholinergic Agonists | 2 | 2010 | 7 | 0.140 |
Why?
|
Phosphodiesterase Inhibitors | 3 | 2009 | 34 | 0.130 |
Why?
|
Potassium | 3 | 2018 | 112 | 0.130 |
Why?
|
Dopamine | 2 | 1995 | 245 | 0.130 |
Why?
|
Neuropeptide Y | 2 | 1999 | 24 | 0.130 |
Why?
|
3',5'-Cyclic-AMP Phosphodiesterases | 2 | 2009 | 6 | 0.130 |
Why?
|
Software Design | 1 | 2015 | 16 | 0.130 |
Why?
|
Liver | 3 | 2009 | 479 | 0.130 |
Why?
|
Neuroprotective Agents | 1 | 2017 | 245 | 0.130 |
Why?
|
Albuterol | 3 | 1991 | 9 | 0.120 |
Why?
|
Receptors, Angiotensin | 2 | 1993 | 12 | 0.120 |
Why?
|
Rod Cell Outer Segment | 1 | 1994 | 8 | 0.120 |
Why?
|
Male | 19 | 2016 | 20025 | 0.120 |
Why?
|
Antioxidants | 3 | 2024 | 416 | 0.120 |
Why?
|
Second Messenger Systems | 1 | 1993 | 14 | 0.120 |
Why?
|
DNA Fragmentation | 2 | 2004 | 92 | 0.120 |
Why?
|
Receptors, Prostaglandin E | 2 | 2008 | 3 | 0.120 |
Why?
|
Delayed-Action Preparations | 1 | 2013 | 60 | 0.110 |
Why?
|
Female | 18 | 2004 | 20969 | 0.110 |
Why?
|
Angiotensin II | 1 | 1993 | 97 | 0.110 |
Why?
|
Esophagus | 2 | 1992 | 42 | 0.110 |
Why?
|
Receptors, Adrenergic, alpha-2 | 2 | 2006 | 39 | 0.110 |
Why?
|
Aminooxyacetic Acid | 1 | 2012 | 3 | 0.110 |
Why?
|
Estrus | 2 | 1989 | 14 | 0.100 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2023 | 421 | 0.100 |
Why?
|
Perfusion | 2 | 2003 | 33 | 0.100 |
Why?
|
Nitrendipine | 2 | 2003 | 2 | 0.100 |
Why?
|
Glutathione | 3 | 2021 | 179 | 0.100 |
Why?
|
Plants, Medicinal | 2 | 2002 | 68 | 0.100 |
Why?
|
Aged | 7 | 2001 | 6741 | 0.100 |
Why?
|
Sympathomimetics | 1 | 1991 | 8 | 0.100 |
Why?
|
Pregnancy, Animal | 1 | 1991 | 16 | 0.100 |
Why?
|
Benzeneacetamides | 1 | 1990 | 6 | 0.100 |
Why?
|
Enzyme Activation | 1 | 2012 | 444 | 0.090 |
Why?
|
Weight Loss | 2 | 2009 | 131 | 0.090 |
Why?
|
Adult | 10 | 2001 | 11712 | 0.090 |
Why?
|
Glyburide | 1 | 2010 | 8 | 0.090 |
Why?
|
1-Methyl-3-isobutylxanthine | 1 | 2009 | 13 | 0.090 |
Why?
|
Dietary Supplements | 2 | 2009 | 208 | 0.090 |
Why?
|
Superoxide Dismutase | 2 | 2021 | 155 | 0.090 |
Why?
|
Hydrogen | 2 | 2021 | 47 | 0.090 |
Why?
|
Glutamine | 1 | 2009 | 40 | 0.090 |
Why?
|
Rats, Sprague-Dawley | 5 | 2004 | 1618 | 0.090 |
Why?
|
Middle Aged | 8 | 2001 | 10129 | 0.090 |
Why?
|
Aging | 1 | 1994 | 664 | 0.090 |
Why?
|
Rats, Inbred Strains | 4 | 1991 | 133 | 0.080 |
Why?
|
Naloxone | 1 | 1989 | 52 | 0.080 |
Why?
|
Narcotics | 1 | 1989 | 32 | 0.080 |
Why?
|
Miotics | 1 | 2008 | 2 | 0.080 |
Why?
|
Sus scrofa | 1 | 2008 | 19 | 0.080 |
Why?
|
Adrenergic beta-Agonists | 1 | 1988 | 28 | 0.080 |
Why?
|
Melatonin | 3 | 2002 | 82 | 0.080 |
Why?
|
Obesity | 2 | 2007 | 1067 | 0.070 |
Why?
|
Biguanides | 2 | 2003 | 7 | 0.070 |
Why?
|
Histamine Agonists | 1 | 2006 | 1 | 0.070 |
Why?
|
Receptors, Histamine | 1 | 2006 | 3 | 0.070 |
Why?
|
Histamine Antagonists | 1 | 2006 | 6 | 0.070 |
Why?
|
Administration, Oral | 2 | 2004 | 224 | 0.070 |
Why?
|
Lipids | 2 | 2004 | 235 | 0.070 |
Why?
|
Ocular Hypotension | 1 | 2005 | 3 | 0.060 |
Why?
|
Insulin Resistance | 1 | 2007 | 184 | 0.060 |
Why?
|
Yohimbine | 2 | 1998 | 26 | 0.060 |
Why?
|
Food Additives | 1 | 2004 | 3 | 0.060 |
Why?
|
Calcium Channels | 2 | 2018 | 76 | 0.060 |
Why?
|
Clonidine | 2 | 1998 | 52 | 0.060 |
Why?
|
Mitochondria | 2 | 2018 | 487 | 0.060 |
Why?
|
Diltiazem | 1 | 2003 | 5 | 0.060 |
Why?
|
Verapamil | 1 | 2003 | 7 | 0.060 |
Why?
|
omega-Conotoxins | 1 | 2003 | 4 | 0.060 |
Why?
|
Kainic Acid | 1 | 2003 | 48 | 0.060 |
Why?
|
Receptors, Glutamate | 1 | 2003 | 27 | 0.060 |
Why?
|
Dizocilpine Maleate | 1 | 2003 | 48 | 0.060 |
Why?
|
Macular Degeneration | 1 | 2024 | 29 | 0.060 |
Why?
|
N-Methylaspartate | 1 | 2003 | 57 | 0.060 |
Why?
|
Polyamines | 1 | 2003 | 30 | 0.060 |
Why?
|
Phytotherapy | 1 | 2004 | 81 | 0.060 |
Why?
|
Cyclic GMP | 2 | 1993 | 47 | 0.060 |
Why?
|
Chromatography, Liquid | 1 | 2023 | 142 | 0.050 |
Why?
|
Tryptamines | 1 | 2002 | 7 | 0.050 |
Why?
|
Dermis | 1 | 2002 | 8 | 0.050 |
Why?
|
Naphthalenes | 1 | 2002 | 38 | 0.050 |
Why?
|
Appetite | 1 | 2002 | 21 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 448 | 0.050 |
Why?
|
Administration, Cutaneous | 1 | 2002 | 43 | 0.050 |
Why?
|
Testis | 1 | 2003 | 187 | 0.050 |
Why?
|
Hypersensitivity, Immediate | 2 | 2000 | 11 | 0.050 |
Why?
|
Inflammation | 1 | 2007 | 618 | 0.050 |
Why?
|
Vitamin E | 1 | 2002 | 61 | 0.050 |
Why?
|
Tandem Mass Spectrometry | 1 | 2023 | 182 | 0.050 |
Why?
|
Thromboxane-A Synthase | 1 | 2001 | 1 | 0.050 |
Why?
|
Isomerism | 1 | 2001 | 63 | 0.050 |
Why?
|
Peptides | 2 | 1998 | 320 | 0.050 |
Why?
|
Isoquinolines | 1 | 2001 | 45 | 0.050 |
Why?
|
Osmolar Concentration | 1 | 2001 | 58 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2006 | 1371 | 0.050 |
Why?
|
Amitrole | 1 | 2000 | 4 | 0.050 |
Why?
|
Benzene Derivatives | 1 | 2000 | 4 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2023 | 935 | 0.050 |
Why?
|
Prostaglandins E | 2 | 1991 | 3 | 0.050 |
Why?
|
Beclomethasone | 1 | 2000 | 2 | 0.050 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2000 | 28 | 0.050 |
Why?
|
Oxidants | 1 | 2000 | 45 | 0.050 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2000 | 19 | 0.050 |
Why?
|
Anti-Asthmatic Agents | 1 | 2000 | 31 | 0.040 |
Why?
|
Reference Standards | 1 | 2019 | 52 | 0.040 |
Why?
|
Acetylcholine | 2 | 1991 | 73 | 0.040 |
Why?
|
Ganglionectomy | 1 | 1999 | 2 | 0.040 |
Why?
|
Ruthenium Red | 1 | 1998 | 4 | 0.040 |
Why?
|
Thapsigargin | 1 | 1998 | 7 | 0.040 |
Why?
|
Oligomycins | 1 | 1998 | 4 | 0.040 |
Why?
|
Calcium-Transporting ATPases | 1 | 1998 | 16 | 0.040 |
Why?
|
Egtazic Acid | 1 | 1998 | 13 | 0.040 |
Why?
|
Neuroeffector Junction | 1 | 1998 | 1 | 0.040 |
Why?
|
Oxymetazoline | 1 | 1998 | 3 | 0.040 |
Why?
|
Adrenergic Fibers | 1 | 1998 | 3 | 0.040 |
Why?
|
Culture Techniques | 1 | 1998 | 24 | 0.040 |
Why?
|
Quinoxalines | 1 | 1998 | 27 | 0.040 |
Why?
|
Chelating Agents | 1 | 1998 | 57 | 0.040 |
Why?
|
omega-Conotoxin GVIA | 1 | 1998 | 6 | 0.040 |
Why?
|
Feeding Behavior | 1 | 2002 | 454 | 0.040 |
Why?
|
Cytosol | 1 | 2018 | 93 | 0.040 |
Why?
|
Blood Flow Velocity | 1 | 2018 | 61 | 0.040 |
Why?
|
Retinal Diseases | 1 | 2017 | 17 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2000 | 259 | 0.040 |
Why?
|
4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone | 1 | 1997 | 1 | 0.040 |
Why?
|
Endoplasmic Reticulum | 1 | 2018 | 105 | 0.040 |
Why?
|
Calcium Signaling | 1 | 2018 | 101 | 0.040 |
Why?
|
Homeostasis | 1 | 1998 | 188 | 0.040 |
Why?
|
Free Radical Scavengers | 1 | 1997 | 66 | 0.040 |
Why?
|
Rats, Inbred F344 | 1 | 1997 | 245 | 0.040 |
Why?
|
Sulfonamides | 2 | 2009 | 80 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2018 | 202 | 0.030 |
Why?
|
8-Bromo Cyclic Adenosine Monophosphate | 1 | 1995 | 15 | 0.030 |
Why?
|
Cytokines | 1 | 1998 | 602 | 0.030 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 1994 | 15 | 0.030 |
Why?
|
Membrane Fluidity | 1 | 1994 | 11 | 0.030 |
Why?
|
Luminescent Measurements | 1 | 1994 | 26 | 0.030 |
Why?
|
Prostaglandin Antagonists | 1 | 1994 | 1 | 0.030 |
Why?
|
Xanthenes | 1 | 1994 | 11 | 0.030 |
Why?
|
Apomorphine | 1 | 1994 | 13 | 0.030 |
Why?
|
Receptors, Melatonin | 1 | 1994 | 12 | 0.030 |
Why?
|
Saralasin | 1 | 1993 | 1 | 0.030 |
Why?
|
Blood Pressure | 1 | 2018 | 646 | 0.030 |
Why?
|
Stimulation, Chemical | 1 | 1993 | 22 | 0.030 |
Why?
|
Phosphatidylinositols | 1 | 1993 | 12 | 0.030 |
Why?
|
Receptors, Dopamine D2 | 1 | 1994 | 73 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 1994 | 144 | 0.030 |
Why?
|
Cell Membrane | 1 | 1994 | 381 | 0.030 |
Why?
|
Prostaglandins E, Synthetic | 1 | 1991 | 1 | 0.030 |
Why?
|
Adolescent | 3 | 1998 | 5363 | 0.020 |
Why?
|
Sodium Channels | 1 | 1991 | 67 | 0.020 |
Why?
|
Epinephrine | 1 | 1991 | 36 | 0.020 |
Why?
|
Receptors, Adrenergic, alpha | 1 | 1990 | 18 | 0.020 |
Why?
|
Indomethacin | 1 | 1990 | 28 | 0.020 |
Why?
|
Hydroxamic Acids | 1 | 1990 | 32 | 0.020 |
Why?
|
Pancreatic Polypeptide | 1 | 1990 | 2 | 0.020 |
Why?
|
Peptide YY | 1 | 1990 | 2 | 0.020 |
Why?
|
Atropine | 1 | 1990 | 13 | 0.020 |
Why?
|
Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide | 1 | 2009 | 1 | 0.020 |
Why?
|
Endometrium | 1 | 1991 | 60 | 0.020 |
Why?
|
Nitrobenzenes | 1 | 2009 | 19 | 0.020 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2009 | 5 | 0.020 |
Why?
|
Benzofurans | 1 | 2009 | 21 | 0.020 |
Why?
|
Biphenyl Compounds | 1 | 2009 | 53 | 0.020 |
Why?
|
Phytohemagglutinins | 2 | 2000 | 13 | 0.020 |
Why?
|
Drug Interactions | 1 | 1990 | 141 | 0.020 |
Why?
|
Enkephalin, Methionine | 1 | 1989 | 7 | 0.020 |
Why?
|
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 1989 | 17 | 0.020 |
Why?
|
Enkephalins | 1 | 1989 | 33 | 0.020 |
Why?
|
Time Factors | 2 | 2004 | 1742 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 1993 | 2379 | 0.020 |
Why?
|
Benzopyrans | 1 | 1988 | 14 | 0.020 |
Why?
|
Guanidines | 1 | 1988 | 17 | 0.020 |
Why?
|
Morphine | 1 | 1989 | 85 | 0.020 |
Why?
|
Pyrroles | 1 | 1988 | 55 | 0.020 |
Why?
|
Papaverine | 1 | 1988 | 2 | 0.020 |
Why?
|
Lipoxygenase Inhibitors | 1 | 1988 | 6 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2009 | 204 | 0.020 |
Why?
|
Ovariectomy | 1 | 1988 | 105 | 0.020 |
Why?
|
Rats, Zucker | 1 | 2007 | 23 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2007 | 112 | 0.020 |
Why?
|
Triglycerides | 1 | 2007 | 138 | 0.020 |
Why?
|
Eating | 1 | 2007 | 166 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 1988 | 284 | 0.020 |
Why?
|
Pregnancy | 1 | 1991 | 1549 | 0.020 |
Why?
|
Disease Progression | 1 | 2007 | 601 | 0.020 |
Why?
|
Signal Transduction | 1 | 1993 | 1908 | 0.020 |
Why?
|
Hematologic Tests | 1 | 2004 | 7 | 0.020 |
Why?
|
Toxicity Tests | 1 | 2004 | 43 | 0.020 |
Why?
|
Brain Diseases | 1 | 2004 | 32 | 0.010 |
Why?
|
ATP Citrate (pro-S)-Lyase | 1 | 2003 | 2 | 0.010 |
Why?
|
Blood Proteins | 1 | 2004 | 66 | 0.010 |
Why?
|
Organ Size | 1 | 2004 | 157 | 0.010 |
Why?
|
Lung Diseases | 1 | 2004 | 61 | 0.010 |
Why?
|
Heart Diseases | 1 | 2004 | 104 | 0.010 |
Why?
|
8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2002 | 6 | 0.010 |
Why?
|
Tropanes | 1 | 2002 | 6 | 0.010 |
Why?
|
Receptors, Serotonin, 5-HT3 | 1 | 2002 | 7 | 0.010 |
Why?
|
Inhalation Exposure | 1 | 2002 | 43 | 0.010 |
Why?
|
Prodrugs | 1 | 2002 | 24 | 0.010 |
Why?
|
CHO Cells | 1 | 2002 | 124 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2004 | 268 | 0.010 |
Why?
|
Tocopherols | 1 | 2002 | 65 | 0.010 |
Why?
|
Leptin | 1 | 2003 | 118 | 0.010 |
Why?
|
Cricetinae | 1 | 2002 | 238 | 0.010 |
Why?
|
Fruit | 1 | 2004 | 173 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2004 | 167 | 0.010 |
Why?
|
Curcumin | 1 | 2002 | 74 | 0.010 |
Why?
|
Risk Assessment | 1 | 2004 | 753 | 0.010 |
Why?
|
Rhinitis, Allergic, Seasonal | 1 | 2000 | 4 | 0.010 |
Why?
|
Th2 Cells | 1 | 2000 | 58 | 0.010 |
Why?
|
Molecular Structure | 1 | 2001 | 492 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2001 | 550 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2000 | 89 | 0.010 |
Why?
|
Body Mass Index | 1 | 2004 | 854 | 0.010 |
Why?
|
Superior Cervical Ganglion | 1 | 1999 | 5 | 0.010 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 1998 | 9 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1998 | 41 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2000 | 236 | 0.010 |
Why?
|
Interleukin-10 | 1 | 1998 | 75 | 0.010 |
Why?
|
Glucocorticoids | 1 | 1998 | 86 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 1999 | 121 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2002 | 1609 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 1998 | 234 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1998 | 356 | 0.010 |
Why?
|
Cell Line | 1 | 2000 | 1354 | 0.010 |
Why?
|
Asthma | 1 | 2000 | 380 | 0.010 |
Why?
|
Receptors, Neuropeptide Y | 1 | 1993 | 8 | 0.010 |
Why?
|
Receptors, Adrenergic | 1 | 1993 | 11 | 0.010 |
Why?
|
Mice | 1 | 2002 | 5913 | 0.010 |
Why?
|
Cromakalim | 1 | 1988 | 1 | 0.010 |
Why?
|
Pinacidil | 1 | 1988 | 1 | 0.010 |
Why?
|
Rubidium Radioisotopes | 1 | 1988 | 2 | 0.010 |
Why?
|
Tetrodotoxin | 1 | 1988 | 22 | 0.010 |
Why?
|
Nifedipine | 1 | 1988 | 10 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1988 | 145 | 0.010 |
Why?
|
Potassium Channels | 1 | 1988 | 75 | 0.000 |
Why?
|
Child | 1 | 1993 | 3131 | 0.000 |
Why?
|